0
Views
2
CrossRef citations to date
0
Altmetric
Expert Opinion

Duloxetine for the treatment of generalized anxiety disorder: a review

&
Pages 23-31 | Published online: 25 Nov 2022

References

  • GreenbergPESisitskyTKesslerRCThe economic burden of anxiety disorders in the 1990sJ Clin Psychiatry199960742743510453795
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th ed text revisionWashington DCAmerican Psychiatric Press, Inc2000
  • KoponenHAllgulanderCEfficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physiciansPrim Care Comp J Clin Psychiatry200792100107
  • WittchenH-UHoynerJGeneralized anxiety disorder: nature and courseJ Clin Psychiatry200162suppl 11:151011414546
  • ButlerGFennelMRobsonPGelderMComparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorderJ Consult Clin Psychol1991591671752002134
  • PreskornSHMilnacipran: A dual norepinephrine and serotonin reuptake pump inhibitorJ Psychiatr Pract20041011912615330407
  • Eli LillyDuloxetine package insert92004 Available at www.insidecymbalta.com
  • Eli Lilly [online] www.lilly.com
  • PreskornSHDuloxetineJ Psychiatr Pract200410637538515583519
  • GuptaSNihalaniNDuloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disordersAnn Clin Psychiatry200719212513217612852
  • SkinnerMHKuanHYSathirakulKDuloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteersClin Pharmacol Ther20037317017712621382
  • Physicians Desk Reference62nd edMontrale, NJThomson Healthcare Inc.200817911798
  • RynnMRussellJEricksonJEfficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible dose, progressive titration, placebo-controlled trialDepress Anxiety200825318218917311303
  • HartfordJKornsteinSLiebowitzMDuloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trialInt Clin Psychopharm200722167174
  • SharmaAGoldbergMJCerimeleBJPharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitorJ Clin Pharmacol20004016116710664922
  • DavidsonJAllgulanderCEfficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studiesHum Psychopharmacol Clin Exp200823519526
  • LantzRJGillespieTARashTJMetabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjectsDrug Metab Dispos2003311142115012920170
  • KarpaKDCavanaughJELakoskiJMDuloxetine pharmacology: Profile of a dual monoamine modulatorCNS Drug Rev2002836137612481192
  • ParikhARThatcherBTTamanoEALiskowBISuicidal ideation associated with duloxetine use: a case seriesJ Clin Psychopharm2008281101102
  • TunisSRStryerDBClancyCMPractical clinical trials: increasing the value of clinical research for decision making in clinical and health policyJAMA20032901624163214506122
  • DavidsonJWittchenHUDuloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trialJ Euro Neuro200818673681
  • PollackMHKornsteinSGSpannMECrits-ChristophPRaskinJRussellJMEarly improvement during duloxetine treatment of generalizedJ Psychiatr Res200842141176118418348888
  • PollackMHExamining quality of life in patient’s with generalized anxiety disorderJ Psychiatr Res.2008doi: 10.1016/j.jpsychires.2007.11.006
  • KesslerRCDuPontRLBerglundPImpairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveysAm J Psychiatry19991561915192310588405
  • EndicottJRussellJMRaskinJDuloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studiesJ Clin Psychiatry200768451852417474806
  • RussellJWeisbergREfficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptomsDepress Anxiety200825E1E1117587217
  • HartfordJEndicottJImplications of pain in generalized anxiety disorder: efficacy of duloxetinePrim Care Companion J Clin Psychiatry2008103
  • RickelsKPollackMHSheehanDVHaskinsJTEfficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorderAm J Psych2000157968974
  • GelenbergALydiardRBRudolphRLAquiarLHaskinsJTSalinasEEfficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6 month randomized controlled trialJAMA2000283233082308810865302
  • US Institute of Health, Clinical Trials Registry Available from www.clinicaltrials.gov

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.